This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  82R22836 AJZ-D
 
  By: Naishtat H.B. No. 3146
 
  Substitute the following for H.B. No. 3146:
 
  By:  Raymond C.S.H.B. No. 3146
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to consent for treatment for chemical dependency in a
  treatment facility and required training for the facility's intake
  personnel.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Sections 462.009(e) and (g), Health and Safety
  Code, are amended to read as follows:
         (e)  Consent given by a patient or by a person authorized by
  law to consent to treatment on the patient's behalf for the
  administration of a medication, therapy, or treatment is valid only
  if:
               (1)  for consent to therapy or treatment:
                     (A)  the consent is given voluntarily and without
  coercive or undue influence; and
                     (B) [(2)]  before administration of the
  [medication,] therapy[,] or treatment, the treating physician or
  the psychologist, social worker, professional counselor, or
  chemical dependency counselor explains to the patient and to the
  person giving consent, in simple, nontechnical language:
                           (i) [(A)]  the specific condition to be
  treated;
                           (ii) [(B)]  the beneficial effects on that
  condition expected from the [medication,] therapy[,] or treatment;
                           (iii) [(C)]  the probable health and mental
  health consequences of not consenting to the [medication,]
  therapy[,] or treatment;
                           (iv) [(D)]  the side effects and risks
  associated with the [medication,] therapy[,] or treatment;
                           (v) [(E)]  the generally accepted
  alternatives to the [medication,] therapy[,] or treatment, if any,
  and whether an alternative might be appropriate for the patient;
  and
                           (vi) [(F)]  the proposed course of the
  [medication,] therapy[,] or treatment;
               (2)  for consent to the administration of medication:
                     (A)  the consent is given voluntarily and without
  coercive or undue influence; and
                     (B)  the treating physician provides each
  explanation required by Subdivision (1)(B) to the patient and to
  the person giving consent in simple, nontechnical language; and
               (3)  for consent to medication, therapy, or treatment, 
  the informed consent is evidenced in the patient's clinical record
  by a signed form prescribed by the commission for this purpose or by
  a statement of the treating physician or the psychologist, social
  worker, professional counselor, or chemical dependency counselor
  who obtained the consent that documents that consent was given by
  the appropriate person and the circumstances under which the
  consent was obtained.
         (g)  Consent given by a patient or by a person authorized by
  law to consent to treatment on the patient's behalf applies to a
  series of doses of medication or to multiple therapies or
  treatments for which consent was previously granted. If the
  treating physician or the psychologist, social worker,
  professional counselor, or chemical dependency counselor obtains
  new information relating to a [medication,] therapy[,] or treatment
  for which consent was previously obtained, the physician or the
  psychologist, social worker, professional counselor, or chemical
  dependency counselor must explain the new information and obtain
  new consent. If the treating physician obtains new information
  relating to a medication for which consent was previously obtained,
  the physician must explain the new information and obtain new
  consent.
         SECTION 2.  The heading to Section 462.025, Health and
  Safety Code, is amended to read as follows:
         Sec. 462.025.  INTAKE, SCREENING, ASSESSMENT, AND
  ADMISSION.
         SECTION 3.  Section 462.025, Health and Safety Code, is
  amended by amending Subsections (a) and (e) and adding Subsection
  (b-1) to read as follows:
         (a)  The commission shall adopt rules governing the
  voluntary admission of a patient to a treatment facility, including
  rules governing the intake, screening, and assessment procedures of
  the admission process.
         (b-1)  The rules governing the screening process shall
  establish minimum standards for determining whether a prospective
  patient presents sufficient signs, symptoms, or behaviors
  indicating a potential chemical dependency disorder to warrant a
  more in-depth assessment by a qualified professional. The screening
  must be reviewed and approved by a qualified professional.
         (e)  In accordance with commission rule, a treatment
  facility shall provide annually a minimum of two [eight] hours of
  inservice training regarding intake and screening [and assessment]
  for persons who will be conducting an intake or screening [or
  assessment] for the facility. A person may not conduct intake or
  screenings [or assessments] without having completed the initial
  and applicable annual inservice training.
         SECTION 4.  Section 462.025(h), Health and Safety Code, is
  amended by amending Subdivision (2) and adding Subdivision (4) to
  read as follows:
               (2)  "Assessment" means the clinical [administrative]
  process a treatment facility uses to gather information from a
  prospective patient, including a medical history and the problem
  for which the patient is seeking treatment, to determine whether a
  prospective patient should be admitted.
               (4)  "Screening" means the process a treatment facility
  uses to determine whether a prospective patient presents sufficient
  signs, symptoms, or behaviors to warrant a more in-depth assessment
  by a qualified professional.
         SECTION 5.  This Act takes effect September 1, 2011.